对阿尔茨海默病的免疫疗法
1Department of Pharmacology and Chemical Biology, Department of Neurology, Center for Neurodegenerative Disease, Goizueta Institute Emory Brain Health, Emory University School of Medicine, Atlanta, GA, USA.
Science (New York, N.Y.)
|December 14, 2023
概括
针对β粉样蛋白斑块的新抗体治疗有望减缓阿尔茨海默病患者的认知衰退. 这些发现为未来的治疗策略提供了希望.
科学领域:
- 神经科学
- 免疫学
- 药理学
背景情况:
- 阿尔茨海默病的特征是大脑中粉样β (Aβ) 积累.
- 这些聚合物被认为有助于神经退行和认知衰退.
- 目前的治疗策略旨在清除或防止这些有毒的Aβ物种的形成.
研究的目的:
- 评估旨在向和中和β-氨基酸聚合物的新型抗体的疗效.
- 评估这些抗体治疗对阿尔茨海默病患者认知能力下降率的影响.
主要方法:
- 临床试验涉及早期至中度阿尔茨海默病患者.
- 针对各种形式的粉样β聚合物的特定抗体的使用.
- 使用标准化神经测试对认知功能的纵向评估.
主要成果:
- 与安慰剂组相比,抗体治疗组表现出认知衰退的统计显著减缓.
- 在接受治疗的个体中观察到粉样β斑块负荷的降低.
- 目标参与与临床益处之间存在相关性.
结论:
- 针对粉样β聚合物的抗体代表了阿尔茨海默病的有前途的治疗方法.
- 通过调节粉样β病理来减缓认知衰退.
- 需要进一步的研究和长期研究来证实安全性和有效性.
相关概念视频
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:26Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
128
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
01:30Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115